<h1 data-pm-slice="1 1 []">Best Fractional CFO Firms for Biotech Startups: 7 Options to Consider</h1>

<p>Selecting the right fractional CFO for a biotechnology startup depends on your development stage, financing strategy, research expenses, and clinical milestones. Some firms specialize in life sciences, while others offer broader financial management services that include biotech companies.</p>
<p>Below are seven fractional CFO providers worth evaluating, presented alphabetically rather than in order of performance.</p>
<ul data-spread="false">
<li>
<p><strong>CFO Advisors:</strong> Supports venture-backed startups with cash runway projections, financial models, and investor reporting.</p>
</li>
<li>
<p><strong>Charles River CFO:</strong> Offers fractional, interim, and outsourced financial services, including experience relevant to SEC reporting and IPO preparation.</p>
</li>
<li>
<p><strong>Danforth Advisors:</strong> Focuses exclusively on life sciences, supporting companies from early-stage accounting through financing and public-market preparation.</p>
</li>
<li>
<p><strong>Fleming CFO:</strong> Provides founder-led, part-time financial leadership for life sciences businesses.</p>
</li>
<li>
<p><strong>G-Squared Partners:</strong> Combines CFO advisory services with accounting support, including clinical trial expense accruals.</p>
</li>
<li>
<p><strong>K-38 Consulting:</strong> Helps startups manage cash flow, develop forecasts, prepare investor reports, and access R&D tax credit services.</p>
</li>
<li>
<p><strong>Startup CFO:</strong> Provides accounting and CFO packages, with services covering research grants and clinical accounting.</p>
</li>
</ul>
<p><strong>Disclosure:</strong> K-38 Consulting prepared this guide and is one of the firms featured. We compete with the other six providers. Readers should evaluate every firm using the same criteria and verify its experience independently. <a href="https://k38consulting.com/biotech-cfo-services/">biotech CFO services</a></p>
<h2>How We Selected These Fractional CFO Firms</h2>
<p>We focused on providers with publicly available information describing their biotech or life sciences services as of November 2026.</p>
<p>Our comparison considered five main factors:</p>
<ul data-spread="false">
<li>
<p><strong>Industry specialization:</strong> Whether biotechnology is the firm's primary focus, a dedicated practice, or one of several industries it serves.</p>
</li>
<li>
<p><strong>Fundraising capabilities:</strong> Experience with financial projections, investor communications, data rooms, and capital planning.</p>
</li>
<li>
<p><strong>Biotech accounting knowledge:</strong> Familiarity with research expenses, clinical trial accruals, grant compliance, and equity transactions.</p>
</li>
<li>
<p><strong>Service structure:</strong> Whether clients work with an individual adviser, a specialist team, or a larger financial services organization.</p>
</li>
<li>
<p><strong>Available evidence:</strong> Published case studies, professional credentials, client examples, and documented results.</p>
</li>
</ul>
<p>No paid placements were included. We have not worked directly inside these organizations, so the descriptions below reflect their published materials rather than independently verified client outcomes.</p>
<h2>Fractional CFO Firms Compared</h2>
<p>Only Startup CFO published pricing on the pages reviewed for this comparison. Contact each provider for a customized proposal, including its fees, deliverables, and expected time commitment.</p>
<h3>1. CFO Advisors</h3>
<p><strong>Best suited for:</strong> Venture-backed biotech startups preparing for IND-related milestones and investor discussions.</p>
<p>CFO Advisors describes services involving cash burn monitoring, multi-scenario runway forecasting, and financial planning around clinical development. Its published materials also discuss board reporting and controls for clinical expenses.</p>
<p>The firm's guidance is associated with managing partner Alex Wu.</p>
<p><strong>What to verify:</strong> Some published information provides general financial guidance rather than detailed evidence of biotech client outcomes. Request relevant references and clarify the firm's current client experience.</p>
<h3>2. Charles River CFO</h3>
<p><strong>Best suited for:</strong> More mature biotechnology companies seeking financial leadership with potential SEC reporting or IPO-related requirements.</p>
<p>Charles River CFO offers fractional, interim, and outsourced finance services. The firm reports serving businesses since 2003 and identifies life sciences among its industry sectors.</p>
<p>Its recruitment materials also reference SEC reporting and IPO experience as desirable qualifications.</p>
<p><strong>What to verify:</strong> Recruitment listings do not necessarily establish the complete scope of current client services. Ask about the specific expertise and availability of the CFO who would lead your engagement.</p>
<h3>3. Danforth Advisors</h3>
<p><strong>Best suited for:</strong> Life sciences companies looking for a specialist financial team with experience across multiple stages of development.</p>
<p>Danforth Advisors concentrates on life sciences and describes services covering operational finance, financing strategy, technical accounting, and IPO preparation. Its published materials have also discussed startup controllership and clinical finance management.</p>
<p>A company announcement from 2019 cited more than 350 life sciences clients.</p>
<p><strong>What to verify:</strong> Some publicly available information is several years old. Request updated staffing details, relevant client examples, and confirmation that the firm supports companies at your current development stage.</p>
<h3>4. Fleming CFO</h3>
<p><strong>Best suited for:</strong> Early-stage life sciences founders who need experienced financial guidance without hiring a full-time CFO.</p>
<p>Founder Gavin Maitland focuses on financial controls, fundraising readiness, investor reporting, and life sciences finance. An ICAS profile identifies him as a Chartered Accountant with an MBA and describes a typical commitment of approximately 10–15 hours per month per client.</p>
<p><strong>What to verify:</strong> Because the service is centered on an individual adviser, ask who provides backup coverage and whether bookkeeping, accounting operations, and compliance are included.</p>
<h3>5. G-Squared Partners</h3>
<p><strong>Best suited for:</strong> Early- and mid-stage biotechnology companies that need accounting operations alongside CFO-level financial planning.</p>
<p>G-Squared Partners describes support for cash runway management, clinical and regulatory scenarios, clinical trial accruals, and audit preparation. The firm also reports helping clients raise more than $600 million in equity and debt across its overall client base.</p>
<p>Its published materials cite a 4.9 ClearlyRated score based on more than 50 clients.</p>
<p><strong>What to verify:</strong> Firm-wide fundraising figures do not establish the amount raised specifically by biotech clients. Ask which team members have direct biotechnology experience and how they handle the accounting complexities of clinical programs.</p>
<h3>6. K-38 Consulting</h3>
<p><strong>Best suited for:</strong> Biotechnology startups that need financial forecasting, runway management, investor reporting, and R&D tax credit support.</p>
<p>K-38 Consulting is based in Raleigh, North Carolina, and was founded by Dallas Alford IV, CPA. Its biotech CFO services focus on cash management, scenario planning, spending oversight, financial forecasting, and investor communications.</p>
<p>The firm also provides R&D tax credit services, which may be relevant to eligible research-intensive companies.</p>
<p><strong>What to verify:</strong> Biotechnology is one of several industries served by K-38 Consulting. Startups that anticipate complex SEC reporting, public-market requirements, or an IPO should confirm whether the firm's capabilities match those needs or consider a specialist provider.</p>
<h3>7. Startup CFO</h3>
<p><strong>Best suited for:</strong> Pre-seed through Series B startups looking for comparatively affordable accounting and financial management packages.</p>
<p>Startup CFO, a service of Rubric Financial, publishes bookkeeping packages starting at $199 per month and CFO support starting at $349 per month. Its listed services include NIH and NSF grant accounting, clinical research organization (CRO) accruals, Single Audit preparation, and SAFE and convertible note accounting.</p>
<p>The company states that its plans include bookkeeping and CPA support and describes its workflow as AI-assisted with expert oversight.</p>
<p><strong>What to verify:</strong> Advertised starting prices may cover a narrower scope than a dedicated fractional CFO engagement. Confirm how many hours of senior financial leadership are included, who reviews the work, and whether the firm can support your financing and clinical reporting requirements.</p>
<h2>How to Choose the Right Fractional CFO for Your Biotech Startup</h2>
<p>The best provider is one whose experience matches your scientific program, financial complexity, and fundraising plans. Before signing an agreement, ask each candidate the following questions.</p>
<p><strong>1. Have you worked with companies at our development stage?</strong></p>
<p>Ask for examples involving comparable technologies, therapeutic areas, and milestones, such as preclinical research, IND-enabling studies, or clinical trials.</p>
<p><strong>2. How do you forecast cash runway?</strong></p>
<p>A useful model should account for research spending, clinical timelines, hiring, regulatory milestones, and expected financing dates. Request examples of scenarios involving delayed studies, increased costs, or a postponed fundraising round.</p>
<p><strong>3. How do you manage CRO accruals?</strong></p>
<p>Clinical research organization contracts, invoices, and actual study progress must be reconciled appropriately. Ask how the team estimates expenses incurred but not yet invoiced and how those estimates are reviewed each month.</p>
<p><strong>4. What experience do you have with research grants?</strong></p>
<p>Determine whether the provider can track allowable expenses, manage indirect cost calculations, prepare required reports, and support audits. Federal award recipients should also establish and apply appropriate indirect cost methodologies consistently.</p>
<p><strong>5. What role will you play during fundraising?</strong></p>
<p>Clarify responsibility for financial models, investor presentations, data room preparation, due diligence responses, and investor meetings. Make sure the engagement covers the support your company actually needs.</p>
<p><strong>6. Can you support audits and financial due diligence?</strong></p>
<p>Ask whether the firm prepares supporting schedules, maintains documentation, coordinates with external auditors, and helps address investor requests.</p>
<p><strong>7. Do you provide R&D tax credit support?</strong></p>
<p>Some eligible small businesses may elect to apply up to $500,000 of qualifying research credits against payroll taxes, subject to applicable requirements. Ask whether the provider handles eligibility analysis, calculations, documentation, and filing or works with a separate tax specialist.</p>
<p><strong>8. Who will manage our account day to day?</strong></p>
<p>Confirm the lead adviser's biotech experience, availability, expected monthly involvement, and backup arrangements.</p>
<h2>When Should a Biotech Startup Hire a Fractional CFO?</h2>
<p>A company does not need to reach a particular revenue threshold before it benefits from financial leadership. In biotechnology, development milestones and financing complexity are often more useful indicators than sales.</p>
<h3>Early research and development</h3>
<p>Founders may be able to manage basic budgeting with a bookkeeper or accountant when operations are simple. However, cash forecasting becomes increasingly important as research programs expand.</p>
<h3>Preparing for the first institutional raise</h3>
<p>A fractional CFO can help develop financial projections, prepare fundraising materials, estimate capital requirements, and explain how funding will support upcoming milestones.</p>
<h3>Entering clinical development</h3>
<p>Clinical programs introduce additional financial complexity, including CRO commitments, trial timelines, regulatory expenses, and uncertain spending requirements. More frequent CFO involvement may become valuable.</p>
<h3>Planning a major financing round or IPO</h3>
<p>A larger financing round, expanded clinical program, or potential public offering can justify a more intensive finance function. Depending on complexity and investor expectations, the company may eventually need a full-time CFO.</p>
<p>Some advisory firms recommend hiring full-time finance leadership several months before a major transaction. Treat such recommendations as planning guidance rather than universal rules.</p>
<h2>What Does a Fractional CFO Cost for a Biotech Startup?</h2>
<p>Pricing depends on the provider's experience, the company's development stage, and the scope of work. Many specialist firms do not publish standard fees.</p>
<p>As a general reference, Exact Partners has cited monthly fractional CFO fees of approximately $3,000–$10,000. This range is not specific to biotechnology and should not be treated as a universal market rate.</p>
<p>Startup CFO's published starting prices are considerably lower, but the service structure and senior involvement may differ substantially from a traditional fractional CFO engagement.</p>
<p>Before comparing quotes, establish whether each proposal includes:</p>
<ul data-spread="false">
<li>
<p>Monthly financial statements and management reporting.</p>
</li>
<li>
<p>Cash runway forecasts and scenario modeling.</p>
</li>
<li>
<p>Fundraising and investor reporting support.</p>
</li>
<li>
<p>Grant accounting and clinical expense management.</p>
</li>
<li>
<p>R&D tax credit support.</p>
</li>
<li>
<p>Audit preparation and due diligence assistance.</p>
</li>
<li>
<p>A defined number of advisory hours and access to senior personnel.</p>
</li>
</ul>
<p>A lower monthly fee may not represent better value if the engagement excludes critical financial responsibilities. Compare deliverables, expertise, and availability before making a decision.</p>
<h2>Frequently Asked Questions</h2>
<h3>What does a fractional CFO do for a biotech startup?</h3>
<p>A fractional CFO provides part-time executive-level financial guidance. Responsibilities can include cash runway forecasting, budget management, fundraising strategy, investor reporting, clinical expense oversight, and financial planning for research and development milestones.</p>
<h3>How is a biotech accountant different from a fractional CFO?</h3>
<p>A biotech accountant primarily maintains financial records, reconciles accounts, and supports accurate reporting. A fractional CFO uses financial information to guide strategic decisions, including spending priorities, fundraising timing, capital allocation, and long-term business planning.</p>
<h3>Do pre-revenue biotech startups need a CFO?</h3>
<p>Not necessarily on a full-time basis. A startup with limited operations may initially need reliable bookkeeping and accounting. Part-time CFO support becomes more valuable when the company approaches an institutional funding round, manages complex grants, or begins planning expensive clinical studies.</p>
<h3>Can a fractional CFO help with NIH or NSF grant accounting?</h3>
<p>Yes, some providers offer grant accounting and financial compliance services. Capabilities vary, so ask whether the firm manages allowable cost tracking, indirect cost calculations, grant reporting, documentation, and audit preparation or only provides strategic advice.</p>
<h3>Can a fractional CFO help a biotech company raise funding?</h3>
<p>Yes. Depending on the engagement, a fractional CFO may prepare financial models, estimate capital requirements, build scenario forecasts, organize financial information for due diligence, and support investor communications. Scientific and clinical fundraising strategy may also require input from experienced biotech executives and advisers.</p>
<h3>When should a biotech startup move from a fractional CFO to a full-time CFO?</h3>
<p>There is no universal threshold. A full-time CFO may become appropriate when the company raises a substantial financing round, expands its clinical programs, builds a larger finance team, prepares for an IPO, or needs daily executive-level financial leadership.</p>
<h3>What should a biotech startup look for in a fractional CFO?</h3>
<p>Prioritize experience with companies at a similar development stage, realistic runway forecasting, clinical trial accounting, grant compliance, fundraising support, and clear communication. Also confirm the adviser's availability, fees, deliverables, and ability to coordinate with accountants, tax specialists, and auditors.</p>
<h3>Is a life sciences-only CFO firm always the best choice?</h3>
<p>No. A specialist firm may offer deeper familiarity with biotech accounting and clinical development, while a broader firm may provide useful expertise in fundraising, tax planning, or general financial operations. The right choice depends on the startup's needs, the assigned team's experience, and the services included.</p>
<h3>How can a startup compare fractional CFO proposals fairly?</h3>
<p>Provide each candidate with the same information about your development stage, funding history, clinical plans, grants, and expected financing milestones. Request written proposals that specify responsibilities, deliverables, senior-level hours, fees, and any excluded services. This makes it easier to compare the actual value of each engagement.</p>
<h2>Final Thoughts</h2>
<p>Choosing a fractional CFO is an important financial decision for a biotech startup. The right adviser can help founders understand their cash runway, manage research and clinical spending, prepare for fundraising, and make better-informed decisions as development progresses.</p>
<p>Evaluate providers based on demonstrated industry experience, the needs of your current stage, and the support you expect to receive. Request references, verify relevant qualifications, and obtain a clearly defined scope of work before committing to a long-term engagement.</p>
<p>For startups focused on runway management, financial forecasting, investor reporting, and R&D tax credit support, K-38 Consulting is one option to evaluate alongside the other firms in this guide. Companies with specialized SEC reporting or IPO requirements should give particular attention to providers with directly relevant experience.</p>
<p>The goal is not simply to hire a CFO at the lowest price. It is to find financial leadership that helps your company use capital effectively and reach its next scientific and business milestones.</p>